Rogier Reijmers

11PUBLICATIONS
71CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsWastewater treatment processes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 05, 2025
Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function.

Marta Barisa, Henrike P Muller, Elisa Zappa

|Dec 23, 2023
SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity.

Panagiota Bouti, Colin Blans, Bart J A M Klein

|Jul 03, 2023
Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy.

Lydia Lee, Wen Chean Lim, Daria Galas-Filipowicz

|Dec 08, 2021
Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence.

Afroditi Katsarou, Maria Sjöstrand, Jyoti Naik

|Nov 13, 2021
An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML.

Dyantha I van der Lee, Georgia Koutsoumpli, Rogier M Reijmers

|Sep 16, 2021
Development of follicular dendritic cells in lymph nodes depends on retinoic acid-mediated signaling.

Jasper J Koning, Anusha Rajaraman, Rogier M Reijmers

Pageof 2

Frequent Collaborators

2 joint publications

Mirjam H M Heemskerk

2 joint publications

Jasper J Koning

1 joint publications

Jie Yang

1 joint publications

Ferry Cornelissen